The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Dubrovina S.O.

FGBU "Rostovskiĭ nauchno-issledovatel'skiĭ institut akusherstva i pediatrii" Minzdravsotsrazvitiia Rossii

Muzalchanova Yu.S.

Federal State Budget Establishment of High Education «Rostov State Medical University» of the Ministry of Health of the Russia, Rostov-on-Don, Russia

Vasil’eva V.V.

Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia

Early prediction of preeclampsia (a review)

Authors:

Dubrovina S.O., Muzalchanova Yu.S., Vasil’eva V.V.

More about the authors

Journal: Russian Journal of Human Reproduction. 2018;24(3): 67‑73

DOI: 10.17116/repro201824367

Read: 1159 times

Download PDF (RU)
Contact the author
Table of contents

EARLY PREDICTION OF PREECLAMPSIA (A REVIEW)
EARLY PREDICTION OF PREECLAMPSIA (A REVIEW)

To cite this article:

Dubrovina SO, Muzalchanova YuS, Vasil’eva VV. Early prediction of preeclampsia (a review). Russian Journal of Human Reproduction. 2018;24(3):67‑73. (In Russ.)
https://doi.org/10.17116/repro201824367

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Epidemiological moni­toring of morbidity in pregnant women in the Russian Fede­ration: trends and medi­cal and orga­nizational prerequisites for adju­sting prevention programs at the popu­lation level. Russian Journal of Human Reproduction. 2025;(2):7-16
Mole­cular mechanisms of preeclampsia. Russian Journal of Human Reproduction. 2025;(2):44-53
Difficult intu­bation risk asse­ssment in bariatric surgery. Russian Journal of Anesthesiology and Reanimatology. 2025;(1):62-68
The level of hypo­xia-induced factor-1a and asso­ciated mole­cules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10
Modern concepts of preeclampsia, taking into account the role of the permeability of the hema­toencephalic barrier. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):11-18
Rela­tionship between stroke-associated pneumonia and long-term outcomes of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):57-61
Prognostic significance of NT-proBNP and sST2 in patients with chro­nic heart failure and redu­ced ejection fraction after previous deco­mpensation. Russian Cardiology Bulletin. 2025;(1):49-56
Morphological markers of mito­chondrial dysfunction of the basal plate cyto­trophoblast of the placenta in preeclampsia of varying seve­rity. Russian Journal of Archive of Pathology. 2025;(2):24-29
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Diagnostic and prognostic pote­ntial of modern biomarkers in community-acquired pneumonia in children. Russian Journal of Preventive Medi­cine. 2025;(4):130-135
Abstract:

In this review, the current data on the classification, pathogenesis and prognosis of one of the severe complications of pregnancy — pre-eclampsia are considered. Analysis of data on the problem of pre-eclampsia leads to the conclusion that the main trend at present is the search for various anamnestic, clinical and biochemical prognostic predictors of the development of this pathology. The most promising direction is to indicate the study of the early implantation period in order to find effective biomarkers that are available in practice and capable of predicting the development and severity of preeclampsia at early gestational age. Current data indicate that the multifactor approach is the most effective and combines various clinical and biochemical predictors to identify women at high risk for developing preeclampsia. Based on the analysis of a large number of literature sources, it was concluded that the search for clinical criteria and the best biomarkers for their prognostic significance continues today, remaining one of the leading trends in scientific research in obstetrics and gynecology, given the significance of preeclampsia.

Keywords:

preeclampsia
gravidae
prognosis

Authors:

Dubrovina S.O.

FGBU "Rostovskiĭ nauchno-issledovatel'skiĭ institut akusherstva i pediatrii" Minzdravsotsrazvitiia Rossii

Muzalchanova Yu.S.

Federal State Budget Establishment of High Education «Rostov State Medical University» of the Ministry of Health of the Russia, Rostov-on-Don, Russia

Vasil’eva V.V.

Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia

Close metadata

References:

  1. Khlestova GV, Karapetyan AO, Shakaya MN, Romanov AYu, Baev OR. Maternal and perinatal outcomes in early and late preeclampsia. Akusherstvo i ginekologija. 2017;6:41-47. (In Russ.) https://doi.org/10.18565/aig.2017.6.41-7
  2. Sidorova IS, Nikitina NA. Preeclampsia in the focus of a practitioner’s attention. Akusherstvo i ginekologija. 2014;6:4-9. (In Russ.)
  3. Lemeshevskaya TV, Pribyshenya OV. Prediction of preeclampsia during extended first-trimester combined prenatal screening. Akusherstvo i ginekologija. 2017; 12:52-59. (In Russ.) https://doi.org/10.18565/aig.2017.12.52-59
  4. Sukhikh GT, Murashko LE. Prejeklampsija. M.: GEOTAR-Media; 2010. (In Russ.)
  5. O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright А, Poon L, Nicolaides K. Competing risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11—13 weeks of gestation. American Journal of Obstetrics and Gynecology. 2016;214(1):1-12. https://doi.org/10.1016/j.ajog.2015.08.034
  6. Gipertenzivnye rasstrojstva vo vremja beremennosti, v rodah i poslerodovom periode. Prejeklampsija. Jeklampsija. Klinicheskie rekomendacii (protokol lechenija). M.2016. Accessed February 19, 2018. (In Russ.) Available at: http://www.uzo.kurgan-med.ru/files/downloads/3483.pdf.
  7. Akusherstvo: Nacional’noe Rukovodstvo. Ed. by Savel’eva GM, Sukhikh GT, Serov VN, Radzinskiy VE. M.: GEOTAR-Media; 2015. (In Russ.)
  8. Henderson J, Thompson J, Burda B, Cantor A. Preeclampsia screening: evidence report and systematic review for the US Preventive Services Task Force. Journal of the American Medical Association. 2017;317(16):1668-1683. https://doi.org/10.1001/jama.2016.18315
  9. Keikkala E, Vuorela P, Laivuori H, Romppanen J, Heinonen S. First trimester hyperglycosylated human chorionic gonadotrophin in serum — a marker of early-onset preeclampsiа. Placenta. 2013;34(11): 1059-1065. https://doi.org/10.1016/j.placenta.2013.08.006
  10. Tayyar A, Krithinakis K, Wright A, Wright D, Nicolaides K. Mean arterial pressure at 12, 22, 32 and 36 weeks’ gestation in screening for pre-eclampsia. Ultrasound in Obstetrics and Gynecology. 2016;47:573-579. https://doi.org/10.1002/uog.15815
  11. Wang C, Wang X, Yang H. Effect of maternal age on pregnancy outcomes in Beijing. Zhonghua Fu Chan Ke Za Zhi. 2017;52(8):514-520. https://doi.org/10.3760/cma.j.issn.0529-567X.2017.08.003
  12. Ali S, Khalil R. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opinion on Therapeutic Targets. 2015;19:1495-1515. https://doi.org/10.1517/14728222.2015.1067684
  13. Sung K, Roh A, Eoh K, Kim E. Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study. Obstetrics and Gynecology Science. 2017;60(2):154-162. https://doi.org/10.5468/ogs.2017.60.2.154
  14. Fantasia H. Low-dose aspirin for the prevention of preeclampsia. Nursing for Women’s Health. 2018;1:87-92. https://doi.org/10.1016/j.nwh.2017.12.002
  15. Timofeeva A, Gusar V, Kan N, Prozorovskaya K, Karapetyan A, Bayev O, Chagovets V, Kliver S, Iakovishina D, Frankevich V, Sukhikh G. Identification of potential early biomarkers of preeclampsia. Placenta. 2018;61:61-71. https://doi.org/10.1016/j.placenta.2017.11.011
  16. Iacobelli S, Bonsante F, Robillard P. Comparison of risk factors and perinatal outcomes in early onset and late onset preeclampsia: a cohort based study in Reunion Island. Journal of Reproductive Immunology. 2017;123:12-16. https://doi.org/10.1016/j.jri.2017.08.005
  17. Jardim L, Rios D, Perucci L, de Sousa L, Gomes K, Dusse L. Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia? Clinica Chimica Acta. 2015;447:34-38. https://doi.org/10.1016/j.cca.2015.05.004
  18. Panaitescu A, Syngelaki A, Prodan N, Akolekar R, Nicolaides K. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound in Obstetrics and Gynecology. 2017;50(2):228-235. https://doi.org/10.1002/uog.17554
  19. Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2014;160(10):695-703. https://doi.org/10.7326/M13-2844
  20. Gallo D, Wright D, Akolekar R, Poon L, Nicolaides K. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks’ gestation. American Journal of Obstetrics and Gynecology. 2016;214(5):1-17. https://doi.org/10.1016/j.ajog.2015.11.016
  21. Salomon C, Yee S, Mitchell M, Rice G. The possible role of extravillous trophoblast-derived exosomes on the uterine spiral arterial remodeling under both normal and pathological conditions. BioMed Research International. 2014;2014:693157 https://doi.org/10.1155/2014/693157
  22. Villa P, Kajantie E, Raikkonen K, Pesonen A, Hamalainen E, Vainio M. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG: An International Journal of Obstetrics and Gynaecology. 2013;120(1):64-74. https://doi.org/10.1111/j.1471-0528.2012.03493.x
  23. Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One. 2014;9(12):113715. https://doi.org/10.1371/journal.pone.0113715
  24. Seshadri Reddy V, Munikumar M, Duggina P, Varma N. A diagnostic test accuracy metaanalysis of maternal serum ischemia-modified albumin for detection of preeclampsia. Journal of Maternal-Fetal and Neonatal Medicine. 2018;24:1-9. https://doi.org/10.1080/14767058.2018.1427724
  25. Lisonkova S, Joseph K. Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease. American Journal of Obstetrics and Gynecology. 2013;209(6):541-544. https://doi.org/10.1016/j.ajog.2013.08.019
  26. Rasmussen S, Irgens L, Espinoza J. Maternal obesity and excess of fetal growth in pre-eclampsia. BJOG: An International Journal of Obstetrics and Gynaecology. 2014;121(11):1351-1357. https://doi.org/10.1111/1471-0528.12677
  27. Arlıer S. Endothelial cell leptin receptors, leptin and interleukin-8 in the pathogenesis of preeclampsia: An in-vitro study. Turkish Journal of Obstetrics and Gynecology. 2017;14(4):220-227. https://doi.org/10.4274/tjod.78545
  28. Roberge S, Bujold E, Nicolaides KH. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. American Journal of Obstetrics and Gynecology.2018:S0002-9378(17)32812-0. https://doi.org/10.1016/j.ajog.2017.12.238
  29. Karampas G, Eleftheriades M, Panoulis K, Rizou M, Haliassos A, Hassiakos D, Vitoratos N, Rizos D. Maternal serum levels of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in pregnancies with preeclampsia and those with a small for gestational age neonate: a longitudinal study. Prenatal Diagnosis. 2014; 34:726-733. https://doi.org/10.1002/pd.4337
  30. Muresan D, Rotar I, Stamatian F. The usefulness of fetal Doppler evaluation in early versus late onset intrauterine growth restriction. Review of the literature. Medical Ultrasonography. 2016;18(1):103-109. https://doi.org/10.11152/mu.2013.2066.181.dop
  31. Nicolaides KH. First-trimester screening for pre-eclampsia: time to act. Ultrasound in Obstetrics and Gynecology. 2017;50(5):663-664. https://doi.org/10.1002/uog.18900
  32. Metcalfe A, Langlois S, Macfarlane J, Vallance H, Joseph K. Prediction of obstetrical risk using maternal serum markers and clinical risk factors. Prenatal Diagnosis. 2013;34(2):172-179. https://doi.org/10.1002/pd.4281
  33. Jim В, Рhipps Е, Polsani S. Emerging New Biomarkers of Preeclampsia. Advances in Chronic Kidney Disease. 2013;20(3):271-279. https://doi.org/10.1053/j.ackd.2013.01.001
  34. Chen C, Jaffe I, Karumanchi S. Pre-eclampsia and cardiovascular disease. Cardiovascular Research. 2014;101(4):579-586. https://doi.org/10.1093/cvr/cvu018
  35. Masoura S, Kalogiannidis I, Makedou K, Theodoridis T, Koiou K, Gerou S, Athanasiadis A, Agorastos T. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2014;175:119-123. https://doi.org/10.1016/j.ejogrb.2014.01.012
  36. Deng Y, Wang H, Lu Y, Liu S, Zhang Q, Huang J, Zhu R, Yang J, Zhang R, Zhang D, Shen W, Ning G, Yang Y. Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis. Endocrinology. 2013;54(5): 1794-1801. https://doi.org/10.1210/en.2012-2126
  37. Redman C, Staff A. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. American Journal of Obstetrics and Gynecology. 2015;213(9)(suppl4):1-11. https://doi.org/10.1016/j.ajog.2015.08.003
  38. North R, McCowan L, Dekker G, Poston L, Chan E.H, Stewart A, Black M, Taylor R, Walker J, Baker P. Clinical risk prediction for preeclampsia in nulliparous women: Development of model in international prospective cohort. British Medical Journal. 2011;342: 1875. https://doi.org/10.1136/bmj.d1875
  39. Olsen R, Woelkers D, Dunsmoor-Su R, Lacoursiere D. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia. American Journal of Obstetrics and Gynecology. 2012;207(3):1-7. https://doi.org/10.1016/j.ajog.2012.06.006
  40. Ananth C, Keyes K, Wapner R. Preeclampsia rates in the United States, 1980—2010: age-period-cohort analysis. British Medical Journal. 2013;347:f6564. https://doi.org/10.1136/bmj.f6564
  41. Yabluchanskiy A. May Y, Iyer R, Hall V, Lindsey M. Matrix metalloproteinase-9: many shades of function in cardiovascular disease. Physiology (Bethesda). 2013;28(6):391-403. https://doi.org/10.1152/physiol.00029.2013
  42. Tsiakkas A, Mendez O, Wright A, Nicolaides K. Maternal serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks’ gestation in screening for preeclampsia. Ultrasound in Obstetrics and Gynecology. 2016;47(4):478-483. https://doi.org/10.1002/uog.15817
  43. Tan M., Koutoulas L, Wright D, Nicolaides K, Poon L. Protocol for the prospective validation study: Screening programme for pre-eclampsia (SPREE). Ultrasound in Obstetrics and Gynecology. 2017;50(2):175-179.
  44. Androutsopoulos G, Gkogkos P, Decavalas G. Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. International Journal of Endocrinology and Metabolism. 2013;11(2):102-106. https://doi.org/10.5812/ijem.5014
  45. Chen J, Khalil R. Matrix metalloproteinases in normal pregnancy and preeclampsia. Progress in Molecular Biology and Translational Science. 2017;148:87-165. https://doi.org/10.1016/bs.pmbts.2017.04.001
  46. Espinoza J, Lee W, Martin S.R, Belfort M. Customized growth curves for identification of large-for-gestational age neonates in pre-eclamptic women. Ultrasound in Obstetrics and Gynecology. 2014;43:165-169. https://doi.org/10.1002/uog.13299
  47. Myatt L, Clifton R.G, Roberts J.M, Spong C, Wapner R, Thorp J. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population? BJOG: An International Journal of Obstetrics and Gynaecology. 2013;120:1183-1191. https://doi.org/10.1111/1471-0528.12128
  48. Nevalainen J, Korpimaki T, Kouru H, Sairanen M, Ryynanen M. Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia. Metabolism. 2017;75:6-15. https://doi.org/10.1016/j.metabol.2017.07.004
  49. Nanda S, Nikoletakis G, Markova D, Poon L.C, Nicolaides K. Maternal serum retinol-binding protein-4 at 11—13 weeks’ gestation in normal and pathological pregnancies. Metabolism. 2013;626:814-819. https://doi.org/10.1016/j.metabol.2012.12.011
  50. Duhig K, Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000Prime Reports. 2015;7:24. https://doi.org/10.12703/p7-24
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.